Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PF-07265028 |
Trade Name | |
Synonyms | PF 07265028|PF07265028 |
Drug Descriptions |
PF-07265028 selectively inhibits MAP4K1 (HPK1), potentially leading to enhanced antitumor immune response and increased tumor cell killing (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | MAP4K1 Inhibitor 7 |
CAS Registry Number | NA |
NCIT ID | C190785 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PF-06801591 + PF-07265028 | PF-06801591 PF-07265028 | 0 | 1 |
PF-07265028 | PF-07265028 | 0 | 1 |